Business Context and Reporting Period
Company: Maximus, Inc. (NYSE: MMS)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year ended September 30, 2024
Business Overview: Maximus provides business process services (BPS), clinical services, and technology solutions to government agencies. Operations are divided into three segments: U.S. Federal Services (52% of revenue), U.S. Services (36% of revenue), and Outside the U.S. (12% of revenue). The company focuses on health and human services, including Medicaid eligibility, veterans' disability assessments, and IT modernization.
Key Financial Metrics
| Metric | Fiscal 2024 | Fiscal 2023 |
|---|---|---|
| Revenue | $5,306.2 million | $4,904.7 million |
| Gross Profit | $1,251.7 million (23.6% margin) | $1,028.6 million (21.0% margin) |
| Operating Income | $488.5 million (9.2% margin) | $294.8 million (6.0% margin) |
| Net Income | $306.9 million | $161.8 million |
| Diluted EPS | $4.99 | $2.63 |
| Operating Cash Flow | $515.3 million | $314.3 million |
| Free Cash Flow (Non-GAAP) | $401.1 million | $223.6 million |
| Total Debt (Funded) | $1,145.8 million | $1,257.5 million |
| Cash and Equivalents | $183.1 million | $65.4 million |
| Backlog | $16.2 billion | $20.7 billion |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 8.2% year-over-year, driven primarily by 8.8% organic growth in U.S. operations. This was fueled by volume growth in core programs and the return to full volumes in Medicaid-related activities (redeterminations) which had been paused in prior years.
- Profitability Expansion: Operating margin improved significantly from 6.0% to 9.2%. This was due to higher operating leverage in the U.S. Services segment and reduced costs associated with a material cybersecurity incident that occurred in fiscal 2023 ($29.3 million in 2023 vs. $2.9 million in 2024).
- Segment Performance:
- U.S. Federal Services: Revenue up 13.9% and operating margin up to 12.2%, driven by clinical assessment volumes (VA contracts) and technology solutions.
- U.S. Services: Revenue up 5.5% with operating margin improving to 12.9% as Medicaid redetermination volumes normalized.
- Outside the U.S.: Revenue declined 4.6% due to divestitures (Italy, Singapore, Canada) and organic declines, but the segment returned to profitability with an operating margin of 1.2% (vs. -1.3% loss in 2023).
- Debt Reduction: Total funded debt decreased by approximately $112 million to $1.15 billion, aided by strong operating cash flows.
Guidance, Outlook, and Risks
- Outlook: Management anticipates consistent revenue and profit margins in the U.S. Federal segment for fiscal 2025. The U.S. Services segment expects margins to revert to a run-rate consistent with Q4 2024 (approx. 11%) as temporary excess volumes conclude. The Outside the U.S. segment is undergoing a portfolio rebalancing to improve performance.
- Contract Recompites: The company is actively managing the recompete of two significant contracts: the CMS Contact Center Operations (1-800-MEDICARE) and VA Medical Disability Examination (MDE) contracts. Maximus has filed protests and lawsuits regarding the CMS contract's labor harmony requirements but expects to continue working uninterrupted until the process concludes.
- Cybersecurity: The company continues to incur costs related to the 2023 MOVEit cybersecurity incident, including litigation and remediation. While costs have decreased significantly from the prior year, the company faces ongoing class action lawsuits and potential regulatory penalties.
- Divestitures: The company divested underperforming international businesses in fiscal 2024 to streamline the Outside the U.S. segment.
- Capital Allocation: The company maintains a $200 million stock repurchase program (with $171.4 million remaining as of year-end) and intends to continue paying regular cash dividends ($0.30 per share declared for Q1 2025).
Investor Verification Checklist
- Cybersecurity Liability: Verify the status of the MOVEit incident litigation and the adequacy of the $8.2 million accrual for the Census Project investigation and other potential penalties.
- Contract Recompites: Monitor the outcome of the CMS 1-800-MEDICARE contract protest and the VA MDE recompete, as these represent a significant portion of the U.S. Federal backlog.
- Backlog Realization: Assess the risk that the $16.2 billion backlog may not be fully realized due to government funding changes, option non-exercise, or contract terminations.
- Interest Rate Exposure: Review the impact of variable interest rates on the unhedged portion of the $1.15 billion debt, noting the effective interest rate of 5.52%.
- U.S. Services Margin Sustainability: Confirm that the margin expansion in the U.S. Services segment is sustainable once temporary Medicaid catch-up work concludes.